The DOI matches its Crossref record; 83 of the 83 references it cites were found in a registry or an index.
Transgenic Fatal Familial Insomnia Mice Indicate Prion Infectivity-Independent Mechanisms of Pathogenesis and Phenotypic Expression of Disease
Open accessAbstract
Fatal familial insomnia (FFI) and a genetic form of Creutzfeldt-Jakob disease (CJD178) are clinically different prion disorders linked to the D178N prion protein (PrP) mutation. The disease phenotype is determined by the 129 M/V polymorphism on the mutant allele, which is thought to influence D178N PrP misfolding, leading to the formation of distinctive prion strains with specific neurotoxic properties. However, the mechanism by which misfolded variants of mutant PrP cause different diseases is not known. We generated transgenic (Tg) mice expressing the mouse PrP homolog of the FFI mutation. These mice synthesize a misfolded form of mutant PrP in their brains and develop a neurological illness with severe sleep disruption, highly reminiscent of FFI and different from that of analogously generated Tg(CJD) mice modeling CJD178. No prion infectivity was detectable in Tg(FFI) and Tg(CJD) brains by bioassay or protein misfolding cyclic amplification, indicating that mutant PrP has disease-encoding properties that do not depend on its ability to propagate its misfolded conformation. Tg(FFI) and Tg(CJD) neurons have different patterns of intracellular PrP accumulation associated with distinct morphological abnormalities of the endoplasmic reticulum and Golgi, suggesting that mutation-specific alterations of secretory transport may contribute to the disease phenotype.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures










![Fig 11 Tg(FFI) and Tg(CJD) neurons show different intracellular PrP accumulations and morphological abnormalities of transport organelles. Cultures of cerebellar granule neurons from non-Tg/Prnp +/+, Tg(FFI-K5+/-)/Prnp 0/0 and Tg(CJD-A21+/-)/Prnp 0/0 mice were fixed and labeled with anti-PrP monoclonal antibody 12B2 using the gold-enhance protocol. WT PrP is mostly found at the plasma membrane (A). D177N/M128 PrP is mostly in the Golgi (B), and D177N/V128 PrP is mostly in the ER, whose cisternae appear enlarged and swollen (C). Scale bar = 250 nm in A, B and C. (D) Quantification of gold particles in different cell compartments. PM, plasma membrane. (E) Quantification of ER and Golgi volumes of cultured cerebellar granule neurons. Data are the mean ± SD of at least 10 cells per specimen. Data for non-Tg/Prnp +/+ and Tg(CJD-A21+/-) neurons in D and E are from [14].](https://figures.cochat.ai/paper-figures/b66c865aa7604feeabc119734ab55c2e/transgenic-fatal-familial-insomnia-mice-indicate-prion-infectivity-independent-figure-11.jpg)

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Fatal Prion Disease in a Mouse Model of Genetic E200K Creutzfeldt-Jakob Disease
Friedman‐Levi, Y., Meiner, Z., Canello, T., Frid, K., Kovács, G. G., Budka, H., Avrahami, D., & Gabizon, R. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002350 · Cited by 79 · cited 1×
“However, prion infectivity developed de novo even in Tg PrP mice with C57BL/6J X 129S5 [50], C57BL/6 X FVB [52], C57BL/6J X CBA/J X 129/Ola [21] and FVB [51, 53] backgrounds, suggesting that a specific allelic composition is not required.”
BackgroundRetractedFriedman‐Levi, Y., Mizrahi, M., Frid, K., Binyamin, O., & Gabizon, R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069583 · Cited by 22 · cited 1×
“In contrast to the mitigating effect on sleep abnormalities, co-expression of WT PrP does not significantly modify the time of onset and progression of motor dysfunction or prolong survival of Tg(FFI) mice, consistent with the dominant mode of inheritance of FFI and with similar observations in other mutant PrP mice […”
ResultRetractedFiji: an open-source platform for biological-image analysis
Schindelin, J., Arganda-Carreras, I., Frise, E., Kaynig, V., Longair, M., Pietzsch, T., Preibisch, S., Rueden, C., Saalfeld, S., Schmid, B., et al. (2012) · Nature Methods · doi:10.1038/nmeth.2019 · Cited by 66,890 · cited 1×
“The volumes of the whole brain and individual brain areas (frontal cortex, hippocampus, thalamus, striatum and cerebellum) were quantified manually using Fiji software [79], after a rigid body registration (6 dof) to a reference image to avoid bias due to bad head positioning.”
MethodNovel Proteinaceous Infectious Particles Cause Scrapie
Prusiner, S. B. (1982) · Science · doi:10.1126/science.6801762 · Cited by 5,118 · cited 1×
“This is a conformationally altered and aggregated isoform of the cellular prion protein (PrP) which propagates by imprinting its aberrant conformation onto native PrP molecules [6].”
BackgroundTwo-Process Model of Sleep Regulation
(2009) · Encyclopedia of Neuroscience · doi:10.1007/978-3-540-29678-2_6166 · Cited by 3,899 · cited 2×
“Slow-wave activity (SWA) during NREM sleep (a measure of sleep drive and depth [17]) and EEG spindles (which characterize this sleep phase) were reduced in Tg(FFI)/Prnp mice.”
BackgroundGlutamate Receptor Ion Channels: Structure, Regulation, and Function
Traynelis, S. F., Wollmuth, L. P., McBain, C. J., Menniti, F. S., Vance, K. M., Ogden, K. K., Hansen, K. B., Yuan, H., Myers, S. J., & Dingledine, R. (2010) · Pharmacological Reviews · doi:10.1124/pr.109.002451 · Cited by 3,568 · cited 13×
“Interestingly, the assembly and trafficking of these receptors are finely tuned in the ER and Golgi [74, 75].”
BackgroundInfluentialSelf-propagation of pathogenic protein aggregates in neurodegenerative diseases
Jucker, M., & Walker, L. C. (2013) · Nature · doi:10.1038/nature12481 · Cited by 1,663 · cited 1×
“There is evidence that aggregated proteins such as amyloid-β in AD, tau in the tauopathies, and α-synuclein in PD, are able to spread in a prion-like manner when inoculated into the mouse brain [62].”
BackgroundNormal development and behaviour of mice lacking the neuronal cell-surface PrP protein
Büeler, H., Fischer, M., Lang, Y., Bluethmann, H., Lipp, H.-P., DeArmond, S. J., Prusiner, S. B., Aguet, M., & Weissmann, C. (1992) · Nature · doi:10.1038/356577a0 · Cited by 1,655 · cited 1×
“Transgenic founders were bred with an inbred colony of Zürich I Prnp mice [77] with a pure C57BL/6J background (C57BL/6J/Prnp; European Mouse Mutant Archive, Monterotondo, Rome, Italy; EM:01723).”
BackgroundPrion Diseases of Humans and Animals: Their Causes and Molecular Basis
Collinge, J. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.519 · Cited by 1,344 · cited 1×
“Prion diseases are progressive and invariably fatal degenerative disorders of the central nervous system (CNS) that affect humans and other animals [1].”
BackgroundThe cell biology of synaptic plasticity: AMPA receptor trafficking
Shepherd, J. D., & Huganir, R. L. (2007) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.23.090506.123516 · Cited by 978 · cited 13×
“Interestingly, the assembly and trafficking of these receptors are finely tuned in the ER and Golgi [74, 75].”
BackgroundInfluentialFischer, M., Rülicke, T., Raeber, A., Sailer, A., Moser, M., Oesch, B., Brandner, S., Aguzzi, A., & Weissmann, C. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00467.x · Cited by 877 · cited 2×
“All transgenic lines used in this study were backcrossed for at least ten generations with C57BL/6J/Prnp mice, with the exception of Tga20 (EM:00181) [25], Tg (CJD-G1) (EM:06144) and Tg(WT-E1) [14] mice which were maintained as inbred hybrid colonies.”
BackgroundMethodPrusiner, S. B., Scott, M., Foster, D., Pan, K.-M., Groth, D., Mirenda, C., Torchia, M., Yang, S.-L., Serban, D., Carlson, G. A., et al. (1990) · Cell · doi:10.1016/0092-8674(90)90134-z · Cited by 871
Telling, G. C., Parchi, P., DeArmond, S. J., Cortelli, P., Montagna, P., Gabizon, R., Mastrianni, J., Lugaresi, E., Gambetti, P., & Prusiner, S. B. (1996) · Science · doi:10.1126/science.274.5295.2079 · Cited by 865
Telling, G. C., Scott, M., Mastrianni, J., Gabizon, R., Torchia, M., Cohen, F. E., DeArmond, S. J., & Prusiner, S. B. (1995) · Cell · doi:10.1016/0092-8674(95)90236-8 · Cited by 857
Brown, P., Gibbs, C. J., Rodgers‐Johnson, P., Asher, D. M., Sulima, M. P., Bacote, A., Goldfarb, L. G., & Gajdusek, D. C. (1994) · Annals of Neurology · doi:10.1002/ana.410350504 · Cited by 817 · cited 1×
“Similarly to other progressive neurodegenerative disorders, such as Alzheimer’s disease (AD) and Parkinson’s disease (PD), frontotemporal dementia and the tauopathies, prion diseases can arise sporadically or be genetically inherited; however, they can also be acquired by infection [3, 4].”
BackgroundPrion protein is necessary for normal synaptic function
Collinge, J., Whittington, M. A., Sidle, K. C. L., Smith, C. J., Palmer, M. S., Clarke, A. R., & Jefferys, J. G. R. (1994) · Nature · doi:10.1038/370295a0 · Cited by 799 · cited 1×
“Thus, WT PrP influences only some aspects of the Tg(FFI) phenotype, perhaps those that are more dependent on a physiological function of PrP in neuronal excitability [44].”
BackgroundIn Vitro Generation of Infectious Scrapie Prions
Castilla, J., Saá, P., Hetz, C., & Soto, C. (2005) · Cell · doi:10.1016/j.cell.2005.02.011 · Cited by 790 · cited 2×
“This allows highly efficient prion replication in a test tube, and is able to amplify the equivalent of a single molecule of PrP [29].”
BackgroundSelf-citationGoldfarb, L. G., Petersen, R. B., Tabaton, M., Brown, P., LeBlanc, A. C., Montagna, P., Cortelli, P., Julien, J., Vital, C., Pendelbury, W. W., et al. (1992) · Science · doi:10.1126/science.1439789 · Cited by 716 · cited 1×
“A typical example is the prion disease linked to the substitution of aspartic acid (D) to asparagine (N) at codon 178, which, depending on the aminoacid encoded at polymorphic site 129, segregates with either FFI (D178N/M129), primarily characterized by severe sleep disorders and autonomic dysfunction, or CJD(178) (D1…”
BackgroundAltered circadian activity rhythms and sleep in mice devoid of prion protein
Tobler, I., Gaus, S. E., Deboer, T., Achermann, P., Fischer, M., Rülicke, T., Moser, M., Oesch, B., McBride, P. A., & Manson, J. C. (1996) · Nature · doi:10.1038/380639a0 · Cited by 663 · cited 1×
“PrP has been assigned a role in promoting sleep continuity and circadian rhythmicity [35].”
BackgroundNon-genetic propagation of strain-specific properties of scrapie prion protein
Bessen, R. A., Kocisko, D. A., Raymond, G. J., Nandan, S., Lansbury, P. T., & Caughey, B. (1995) · Nature · doi:10.1038/375698a0 · Cited by 525 · cited 1×
“Different prion diseases are thought to be enciphered in distinctive conformations of the PrP molecule (prion strains) [24, 58].”
BackgroundFamilial and sporadic fatal insomnia
Montagna, P., Gambetti, P., Cortelli, P., & Lugaresi, E. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00323-5 · Cited by 354 · cited 5×
“FFI patients [32], and we found that the circadian organization of sleep and motor activity was lost in Tg(FFI)/Prnp mice.”
BackgroundInfluentialMonari, L., Chen, S. G., Brown, P., Parchi, P., Petersen, R. B., Mikol, J., Gray, F., Cortelli, P., Montagna, P., & Ghetti, B. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.7.2839 · Cited by 334 · cited 3×
“After deglycosylation with PNGaseF, the PK-resistant fragment had an apparent molecular mass of 19 kDa (Fig 1F, lane 2), consistent with observations in FFI patients [16].”
BackgroundResultInfluentialA vector for expressing foreign genes in the brains and hearts of transgenic mice
Borchelt, D. R., Davis, J., Fischer, M., Lee, M. K., Slunt, H. H., Ratovitsky, T., Regard, J., Copeland, N. G., Jenkins, N. A., Sisodia, S. S., et al. (1996) · Genetic Analysis: Biomolecular Engineering · doi:10.1016/s1050-3862(96)00167-2 · Cited by 317 · cited 1×
“Xho vector, which contains a 12 kb fragment of Prnp, including the promoter and intron 1, and drives the expression of transgenic PrP in a tissue pattern similar to that of the endogenous protein [14, 76].”
BackgroundNeurological Illness in Transgenic Mice Expressing a Prion Protein with an Insertional Mutation
Chiesa, R., Piccardo, P., Ghetti, B., & Harris, D. A. (1998) · Neuron · doi:10.1016/s0896-6273(00)80653-4 · Cited by 310 · cited 14×
“The status of the Prnp gene and the presence of the transgene were determined by PCR, and the zygosity of the transgene by RT-PCR [13].”
BackgroundMethodInfluentialSelf-citationSpecies-barrier-independent prion replication in apparently resistant species
Hill, A. F., Joiner, S., Linehan, J., Desbruslais, M., Lantos, P. L., & Collinge, J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.18.10248 · Cited by 295 · cited 1×
“Thus the in vitro converted mutant PrPs were able to propagate in vivo as authentic prions, but produced subclinical infections, most likely because of differences between the primary structure of the mutant PrP in the infecting inoculum andWT PrP in the recipient mice [30, 31].”
BackgroundVariably protease‐sensitive prionopathy: A new sporadic disease of the prion protein
Zou, W., Puoti, G., Xiao, X., Yuan, J., Qing, L., Cali, I., Shimoji, M., Langeveld, J. P. M., Castellani, R., Notari, S., et al. (2010) · Annals of Neurology · doi:10.1002/ana.22094 · Cited by 279 · cited 2×
“None of the brains from inoculated C57BL/6J, Tg(WT-E1+/+) or Tga20 host mice that were subjected to biochemical analysis contained PrP that was detergent-insoluble or that yielded typical or atypical (i.e. 1E4- or SAF84-immunoreactive [27, 28]) PK-resistant fragments.”
Self-citationPrion protein attenuates excitotoxicity by inhibiting NMDA receptors
Khosravani, H., Zhang, Y., Tsutsui, S., Hameed, S., Altier, C., Hamid, J., Chen, L., Villemaire, M., Ali, Z., Jirik, F. R., et al. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200711002 · Cited by 275
Acquired prion disease: iatrogenic CJD, variant CJD, kuru
Will, R. G. (2003) · British Medical Bulletin · doi:10.1093/bmb/66.1.255 · Cited by 248 · cited 1×
“Similarly to other progressive neurodegenerative disorders, such as Alzheimer’s disease (AD) and Parkinson’s disease (PD), frontotemporal dementia and the tauopathies, prion diseases can arise sporadically or be genetically inherited; however, they can also be acquired by infection [3, 4].”
BackgroundManson, J. C. (1999) · The EMBO Journal · doi:10.1093/emboj/18.23.6855 · Cited by 246 · cited 7×
“CJD, FFI and GerstmannSträussler-Scheinker (GSS) syndrome are the most common forms in humans; scrapie of the goat and sheep, bovine spongiform encephalopathy, and chronic wasting disease of deer and elk are the best-known prion zoonoses [2].”
BackgroundInfluentialDeleault, N. R., Piro, J. R., Walsh, D. J., Wang, F., Ma, J., Geoghegan, J. C., & Supattapone, S. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1204498109 · Cited by 245 · cited 1×
“It is possible that the genetic makeup of ki-3F4-FFI mice favors generation of prion infectivity, for example because co-factors that might promote PrP formation [55, 56] are selectively expressed or enriched in these animals.”
BackgroundPrion protein NMR structure and familial human spongiform encephalopathies
Riek, R., Wider, G., Billeter, M., Hornemann, S., Glockshuber, R., & Wüthrich, K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.20.11667 · Cited by 244 · cited 1×
“There is evidence that D178N/M129 and D178N/V129 PrPs differ in their folding and supramolecular assembly [10–12], but how conformational variants of the PrP polypeptide produce different diseases is not clear.”
BackgroundYou, H., Tsutsui, S., Hameed, S., Kannanayakal, T. J., Chen, L., Xia, P., Engbers, J. D. T., Lipton, S. A., Stys, P. K., & Zamponi, G. W. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1110789109 · Cited by 243 · cited 1×
“PrP interacts physically with the NR1 and NR2D subunits of N-methyl-D-aspartate (NMDA) and the GluA1 and GluA2 subunits of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors, and these interactions are important for normal neuronal physiology and survival [71–73].”
BackgroundDrisaldi, B., Stewart, R. S., Adles, C., Stewart, L. R., Quaglio, E., Biasini, E., Fioriti, L., Chiesa, R., & Harris, D. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m213247200 · Cited by 227 · cited 1×
“We have reported that mouse PrP molecules carrying the D177N mutation are delayed in their biosynthetic maturation and are partially retained in transport organelles of the secretory pathway [14, 64–66].”
BackgroundSelf-citationFatal familial insomnia: Clinical and pathologic study of five new cases
Manetto, V., Medori, R., Cortelli, P., Montagna, P., Tinuper, P., Baruzzi, A., Rancurel, G., Hauw, J. J., Vanderhaeghen, J.-J., Mailleux, P., et al. (1992) · Neurology · doi:10.1212/wnl.42.2.312 · Cited by 204
Self-citationDe novo generation of a transmissible spongiform encephalopathy by mouse transgenesis
Sigurdson, C. J., Nilsson, K. P. R., Hornemann, S., Heikenwalder, M., Manco, G., Schwarz, P., Ott, D., Rülicke, T., Liberski, P. P., Julius, C., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810680105 · Cited by 186 · cited 1×
“However, prion infectivity developed de novo even in Tg PrP mice with C57BL/6J X 129S5 [50], C57BL/6 X FVB [52], C57BL/6J X CBA/J X 129/Ola [21] and FVB [51, 53] backgrounds, suggesting that a specific allelic composition is not required.”
BackgroundPrion Diseases: What Is the Neurotoxic Molecule?
Chiesa, R., & Harris, D. A. (2001) · Neurobiology of Disease · doi:10.1006/nbdi.2001.0433 · Cited by 160 · cited 2×
“Mastrianni, personal communication]—suggests that the disease-encoding properties of mutant PrP are enciphered in misfolded conformations of the protein that are toxic but not infectious [60, 61].”
BackgroundResultSelf-citationRegional distribution of protease‐resistant prion protein in fatal familial insomnia
Parchi, P., Castellani, R., Cortelli, P., Montagna, P., Chen, S. G., Petersen, R. B., Manetto, V., Vnencak‐Jones, C. L., McLean, M. J., Sheller, J. R., et al. (1995) · Annals of Neurology · doi:10.1002/ana.410380107 · Cited by 159 · cited 2×
“Although PrP accumulates to lower levels in FFI than in other human prion diseases, widespread protease-resistant PrP deposits can be detected by immunohistochemistry in the CNS of FFI patients, especially in cases of long duration [47].”
BackgroundImmunodetection of disease‐associated mutant PrP, which accelerates disease in GSS transgenic mice
Nazor, K. E., Kühn, F., Seward, T. S., Green, M. A., Zwald, D., Pürro, M., Schmid, J., Biffiger, K., Power, A. M., Oesch, B., et al. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600717 · Cited by 150 · cited 1×
“Thus the appearance of neurological illness and its rate of progression were correlated with the expression level of mutant PrP, similar to other mouse models of genetic prion disease [13, 14, 19–21].”
BackgroundMolecular Distinction between Pathogenic and Infectious Properties of the Prion Protein
Chiesa, R., Piccardo, P., Quaglio, E., Drisaldi, B., Si-Hoe, S. L., Takao, M., Ghetti, B. F., & Harris, D. A. (2003) · Journal of Virology · doi:10.1128/jvi.77.13.7611-7622.2003 · Cited by 148 · cited 2×
“As positive controls, some host mice were inoculated with the mouse-adapted RML isolate of scrapie that had been previously passaged in WT or Tg(WT-E1) mice (RML and RML, respectively) [26].”
BackgroundSelf-citationFirst experimental transmission of fatal familial insomnia
Tateishi, J., Brown, P., Kitamoto, T., Hoque, Z., Roos, R. P., Wollman, R. L., Červen̆áková, L., & Gajdusek, D. C. (1995) · Nature · doi:10.1038/376434a0 · Cited by 147 · cited 1×
“The Brains of Spontaneously Ill Tg(FFI) and Tg(CJD) Mice Do Not Contain Detectable Prion Infectivity Intracerebral inoculation of brain homogenates from FFI and CJD patients induced prion disease in experimental animals [22–24], consistent with the contention that D178N PrP can spontaneously acquire an infectious stru…”
BackgroundDossena, S., Imeri, L., Mangieri, M., Garofoli, A., Ferrari, L. L., Senatore, A., Restelli, E., Balducci, C., Fiordaliso, F., Salio, M., et al. (2008) · Neuron · doi:10.1016/j.neuron.2008.09.008 · Cited by 146
Self-citationSpontaneous Generation of Prion Infectivity in Fatal Familial Insomnia Knockin Mice
Jackson, W. S., Borkowski, A. W., Faas, H., Steele, A. D., King, O. D., Watson, N., Jasanoff, A., & Lindquist, S. L. (2009) · Neuron · doi:10.1016/j.neuron.2009.07.026 · Cited by 145 · cited 6×
“However, small amounts of protease resistant PrP were detected when 20 mg of total brain homogenates from two-year-old ki-3F4-FFI mice was PK digested and concentrated by trichloroacetic acid precipitation [41].”
BackgroundMethodInfluentialChiesa, R., Drisaldi, B., Quaglio, E., Migheli, A., Piccardo, P., Ghetti, B. F., & Harris, D. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.10.5574 · Cited by 145 · cited 1×
“In contrast to the mitigating effect on sleep abnormalities, co-expression of WT PrP does not significantly modify the time of onset and progression of motor dysfunction or prolong survival of Tg(FFI) mice, consistent with the dominant mode of inheritance of FFI and with similar observations in other mutant PrP mice […”
ResultSelf-citationPrion protein facilitates uptake of zinc into neuronal cells
Watt, N. T., Taylor, D. R., Kerrigan, T. L., Jarosz-Griffiths, H., Rushworth, J. V., Whitehouse, I. J., & Hooper, N. M. (2012) · Nature Communications · doi:10.1038/ncomms2135 · Cited by 144 · cited 1×
“Moreover, different mutants interact differently with receptor subunit isoforms expressed in functionally distinct neurons of the brain [73].”
BackgroundThe Expanding Universe of Prion Diseases
Watts, J. C., Balachandran, A., & Westaway, D. A. (2006) · PLoS Pathogens · doi:10.1371/journal.ppat.0020026 · Cited by 137 · cited 1×
“CJD, FFI and GerstmannSträussler-Scheinker (GSS) syndrome are the most common forms in humans; scrapie of the goat and sheep, bovine spongiform encephalopathy, and chronic wasting disease of deer and elk are the best-known prion zoonoses [2].”
BackgroundConformational diversity in prion protein variants influences intermolecular β‐sheet formation
Lee, S., Antony, L., Hartmann, R., Knaus, K. J., Surewicz, K. A., Surewicz, W. K., & Yee, V. C. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.333 · Cited by 127
The genetics of prion diseases
Mastrianni, J. A. (2010) · Genetics in Medicine · doi:10.1097/gim.0b013e3181cd7374 · Cited by 125 · cited 2×
“Different PRNPmutations are associated with distinct clinical and neuropathological phenotypes: CJD, FFI, GSS, PrP-cerebral amyloid angiopathy [7] and a recently described PrP systemic amyloidosis [8].”
BackgroundFioriti, L., Dossena, S., Stewart, L. R., Stewart, R. S., Harris, D. A., Forloni, G., & Chiesa, R. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m412441200 · Cited by 123 · cited 1×
“in transfected cells [65, 67], and may reflect the way these mutants acquire abnormal conformations and aggregate during secretory transport [68].”
BackgroundSelf-citationDe novo generation of prion strains
Colby, D. W., & Prusiner, S. B. (2011) · Nature Reviews Microbiology · doi:10.1038/nrmicro2650 · Cited by 101 · cited 1×
“The infectious agent (prion) is scrapie prion protein (PrP) [5].”
BackgroundBrown, P., Goldfarb, L. G., Kovanen, J., Haltia, M., Cathala, F., Sulima, M. P., Gibbs, C. J., & Gajdusek, D. C. (1992) · Annals of Neurology · doi:10.1002/ana.410310309 · Cited by 95
Sforza, E., Montagna, P., Tinuper, P., Cortelli, P., Avoni, P., Ferrillo, F., Petersen, R. B., Gambetti, P. L., & Lugaresi, E. (1995) · Electroencephalography and Clinical Neurophysiology · doi:10.1016/0013-4694(94)00318-f · Cited by 95 · cited 2×
“The amount of REM sleep is also significantly decreased in Tg (FFI)/Prnp mice, as often happens in FFI patients at a late stage of disease [33].”
BackgroundFatal familial insomnia: a new Austrian family
Almer, G., Hainfellner, J. A., Brücke, T., Jellinger, K. A., Kleinert, R., Bayer, G., Windl, O., Kretzschmar, H. A., Hill, A. F., Sidle, K. C. L., et al. (1999) · Brain · doi:10.1093/brain/122.1.5 · Cited by 92 · cited 3×
“These include fine-granular synaptic-type and focal PrP deposits, patchy and strip-like immunoreactive profiles, as well as intravacuolar and cytoplasmic PrP accumulations in neurons [40].”
BackgroundDaude, N., Lehmann, S., & Harris, D. A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.17.11604 · Cited by 91 · cited 1×
“in transfected cells [65, 67], and may reflect the way these mutants acquire abnormal conformations and aggregate during secretory transport [68].”
BackgroundWatts, J. C., Giles, K., Stöhr, J., Oehler, A., Bhardwaj, S., Grillo, S. K., Patel, S. S., DeArmond, S. J., & Prusiner, S. B. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1121556109 · Cited by 91 · cited 1×
“However, prion infectivity developed de novo even in Tg PrP mice with C57BL/6J X 129S5 [50], C57BL/6 X FVB [52], C57BL/6J X CBA/J X 129/Ola [21] and FVB [51, 53] backgrounds, suggesting that a specific allelic composition is not required.”
BackgroundAnalogs of the Golgi complex in microsporidia: structure and avesicular mechanisms of function
Beznoussenko, G. V., Dolgikh, V. V., Seliverstova, E. V., Semenov, P. B., Tokarev, Y. S., Trucco, A., Micaroni, M., Giandomenico, D. D., Auinger, P., Senderskiy, I. V., et al. (2007) · Journal of Cell Science · doi:10.1242/jcs.03402 · Cited by 89 · cited 1×
“Electron tomography and three-dimensional reconstruction was done as described [81].”
MethodSelf-citationBaracchi, F., & Opp, M. R. (2008) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2008.02.001 · Cited by 88
Self-citationFatal familial insomnia: Clinical features and early identification
Krasnianski, A., Bartl, M., Juan, P. J. S., Heinemann, U., Meißner, B., Varges, D., Schulze‐Sturm, U., Kretzschmar, H. A., Schulz‐Schaeffer, W., & Zerr, I. (2008) · Annals of Neurology · doi:10.1002/ana.21358 · Cited by 84 · cited 1×
“motor deficits [32, 45].”
Spontaneous generation of anchorless prions in transgenic mice
Stöhr, J., Watts, J. C., Legname, G., Oehler, A., Lemus, A., Nguyen, H.-O. B., Sussman, J., Wille, H., DeArmond, S. J., Prusiner, S. B., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1117827108 · Cited by 80 · cited 1×
“However, prion infectivity developed de novo even in Tg PrP mice with C57BL/6J X 129S5 [50], C57BL/6 X FVB [52], C57BL/6J X CBA/J X 129/Ola [21] and FVB [51, 53] backgrounds, suggesting that a specific allelic composition is not required.”
BackgroundApetri, A. C., Vanik, D. L., & Surewicz, W. K. (2005) · Biochemistry · doi:10.1021/bi051455+ · Cited by 80 · cited 3×
“The Brains of Spontaneously Ill Tg(FFI) and Tg(CJD) Mice Do Not Contain Detectable Prion Infectivity Intracerebral inoculation of brain homogenates from FFI and CJD178 patients induced prion disease in experimental animals [22–24], consistent with the contention that D178N PrP can spontaneously acquire an infectious s…”
BackgroundMcLean, C., Storey, E., Gardner, R. J. M., Tannenberg, A. E. G., Cervenáková, L., & Brown, P. (1997) · Neurology · doi:10.1212/wnl.49.2.552 · Cited by 78
Tinuper, P., Montagna, P., Medori, R., Cortelli, P., Zucconi, M., Baruzzi, A., & Lugaresi, E. (1989) · Electroencephalography and Clinical Neurophysiology · doi:10.1016/0013-4694(89)90190-9 · Cited by 76 · cited 1×
“5–2 Hz (similar to the periodic sharp-wave complexes in the EEG activity of CJD patients) may appear in advanced stages of the long-evolution cases of FFI [32–34].”
BackgroundSenatore, A., Colleoni, S., Verderio, C., Restelli, E., Morini, R., Condliffe, S. B., Bertani, I., Mantovani, S., Canovi, M., Micotti, E., et al. (2012) · Neuron · doi:10.1016/j.neuron.2012.02.027 · Cited by 75
Self-citationPhenotypic variability in fatal familial insomnia (D178N-129M) genotype
Zerr, I., Giese, A., Windl, O., Kropp, S., Schulz‐Schaeffer, W., Riedemann, C., Skworc, K., Bodemer, M., Kretzschmar, H. A., & Poser, S. (1998) · Neurology · doi:10.1212/wnl.51.5.1398 · Cited by 74
A New Mechanism for Transmissible Prion Diseases
Makarava, N., Kovács, G. G., Savtchenko, R. S., Alexeeva, I., Ostapchenko, V. G., Budka, H., Rohwer, R. G., & Baskakov, I. V. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.6351-11.2012 · Cited by 71 · cited 2×
“None of the brains from inoculated C57BL/6J, Tg(WT-E1+/+) or Tga20 host mice that were subjected to biochemical analysis contained PrP that was detergent-insoluble or that yielded typical or atypical (i.e. 1E4- or SAF84-immunoreactive [27, 28]) PK-resistant fragments.”
Cyclic Amplification of Protein Misfolding and Aggregation
Saá, P., Castilla, J., & Soto, C. A. (2005) · Humana Press eBooks · doi:10.1385/1-59259-874-9:053 · Cited by 71 · cited 1×
“The detailed protocol for serial PMCA has been published elsewhere [82].”
MethodSelf-citationYang, W., Cook, J., Rassbach, B., Lemus, A., DeArmond, S. J., & Mastrianni, J. A. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.2542-09.2009 · Cited by 70
Aggregated, Wild-Type Prion Protein Causes Neurological Dysfunction and Synaptic Abnormalities
Chiesa, R., Piccardo, P., Biasini, E., Ghetti, B. F., & Harris, D. A. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.3109-08.2008 · Cited by 65 · cited 1×
“Transgenic mice expressing WT PrP up to seven times the endogenous level remain healthy during their lifetime [13, 42], and have normal sleep-wake behavior [14], strongly indicating that the Tg(FFI) phenotype is not a mere consequence of overexpression, but is due to the D177N/M128 mutation.”
BackgroundSelf-citationCold Exposure and Sleep in the Rat: REM Sleep Homeostasis and Body Size
Amici, R., Cerri, M., Ocampo-Garcés, A., Baracchi, F., Dentico, D., Jones, C. A., Luppi, M., Perez, E., Parmeggiani, P. L., & Zamboni, G. (2008) · SLEEP · doi:10.1093/sleep/31.5.708 · Cited by 60 · cited 1×
“During the next 18 h, they did not fully recover (Fig 5B) and compensated the loss of NREM sleep with an increase in the power of the EEG delta band in the first 6 h of recovery (Fig 4), as previously shown for rodents deprived of sleep by gentle handling for a short time [18].”
BackgroundSelf-citationThe Elusive Role of the Prion Protein and the Mechanism of Toxicity in Prion Disease
Chiesa, R. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1004745 · Cited by 56 · cited 2×
“Mastrianni, personal communication]—suggests that the disease-encoding properties of mutant PrP are enciphered in misfolded conformations of the protein that are toxic but not infectious [60, 61].”
BackgroundResultSelf-citationGiaccone, G., Canciani, B., Puoti, G., Rossi, G., Goffredo, D., Iussich, S., Fociani, P., Tagliavini, F., & Bugiani, O. (2000) · Brain Pathology · doi:10.1111/j.1750-3639.2000.tb00240.x · Cited by 55 · cited 1×
“For PrP immunohistochemistry, sections were incubated with PK (2 μg/ml in H2O) for 1 h at room temperature, and exposed to guanidine thyocianate (3M in H2O) for 30 min [80].”
MethodSelf-citationA new prion disease: relationship with central and peripheral amyloidoses
Mead, S., & Reilly, M. M. (2015) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.263 · Cited by 49 · cited 1×
“Different PRNPmutations are associated with distinct clinical and neuropathological phenotypes: CJD, FFI, GSS, PrP-cerebral amyloid angiopathy [7] and a recently described PrP systemic amyloidosis [8].”
BackgroundNon‐infectious aggregates of the prion protein react with several PrPSc‐directed antibodies
Biasini, E., Seegulam, M. E., Patti, B. N., Solforosi, L., Medrano, A. Z., Christensen, H. M., Senatore, A., Chiesa, R., Williamson, R. A., & Harris, D. A. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05306.x · Cited by 48 · cited 1×
“In this regard, we have found that infectious and non-infectious forms of PG14 PrP are structurally related but differ in their oligomeric state and degree of PK resistance [26, 48, 57].”
BackgroundSelf-citationQuaglio, E., Restelli, E., Garofoli, A., Dossena, S., Luigi, A. D., Tagliavacca, L., Imperiale, D., Migheli, A., Salmona, M., Sitia, R., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019339 · Cited by 39 · cited 1×
“We have reported that mouse PrP molecules carrying the D177N mutation are delayed in their biosynthetic maturation and are partially retained in transport organelles of the secretory pathway [14, 64–66].”
BackgroundSelf-citationBiasini, E., Medrano, A. Z., Thellung, S., Chiesa, R., & Harris, D. A. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05082.x · Cited by 39 · cited 1×
“In this regard, we have found that infectious and non-infectious forms of PG14 PrP are structurally related but differ in their oligomeric state and degree of PK resistance [26, 48, 57].”
BackgroundSelf-citationMassignan, T., Biasini, E., Lauranzano, E., Veglianese, P., Pignataro, M., Fioriti, L., Harris, D. A., Salmona, M., Chiesa, R., & Bonetto, V. (2009) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m900271-mcp200 · Cited by 38 · cited 1×
“in transfected cells [65, 67], and may reflect the way these mutants acquire abnormal conformations and aggregate during secretory transport [68].”
BackgroundSelf-citationTaniwaki, Y. (2000) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.68.3.388 · Cited by 36
Diffuse thalamic degeneration in fatal familial insomnia. A morphometric study
Macchi, G., Rossi, G., Abbamondi, A. L., Giaccone, G., Mancia, D., Tagliavini, F., & Bugiani, O. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00902-5 · Cited by 33 · cited 1×
“Thalamic degeneration is the most marked neuropathological change in FFI patients, who frequently also have degenerated cerebella [36, 40, 46], and reduced thalamic and cerebellar volumes were detected by MRI in Tg(FFI) mice in the advanced stage of disease.”
BackgroundSelf-citationSynaptic Dysfunction in Prion Diseases: A Trafficking Problem?
Senatore, A., Restelli, E., & Chiesa, R. (2013) · International Journal of Cell Biology · doi:10.1155/2013/543803 · Cited by 31 · cited 2×
“Thus, different mutant PrPs may have different effects on the function and survival of different neurons—hence on the clinical presentation of disease—depending on where in the secretory pathway they preferentially localize, and how this interferes with the transport of the molecules they interact with [70].”
BackgroundSelf-citationThe hydrophobic core region governs mutant prion protein aggregation and intracellular retention
Biasini, E., Tapella, L., Restelli, E., Pozzoli, M., Massignan, T., & Chiesa, R. (2010) · Biochemical Journal · doi:10.1042/bj20100615 · Cited by 31 · cited 1×
“There is evidence, in fact, that the M/V 129 polymorphism influences the kinetics of misfolding and oligomerization of D178N PrP [11], and oligomerization and intracellular retention of this mutant are closely related [69].”
BackgroundSelf-citationSpontaneous Generation of Infectious Prion Disease in Transgenic Mice
Torres, J. M., Castilla, J., Pintado, B., Gutiérrez‐Adán, A., Andréoletti, O., Aguilar‐Calvo, P., Arroba, A. I., Parra, B., Ferrer, I., Manzanares, J., et al. (2013) · Emerging infectious diseases · doi:10.3201/eid1912.130106 · Cited by 29 · cited 1×
“However, prion infectivity developed de novo even in Tg PrP mice with C57BL/6J X 129S5 [50], C57BL/6 X FVB [52], C57BL/6J X CBA/J X 129/Ola [21] and FVB [51, 53] backgrounds, suggesting that a specific allelic composition is not required.”
BackgroundSelf-citationLugaresi, E., & Montagna, P. (2003) · Springer eBooks · doi:10.1007/978-1-4615-0217-3_52 · Cited by 27
Tapella, L., Stravalaci, M., Bastone, A., Biasini, E., Gobbi, M., & Chiesa, R. (2013) · Biochemical Journal · doi:10.1042/bj20130563 · Cited by 16
Self-citationSpreading proteins in neurodegeneration: where do they take us?
Mallucci, G. R. (2013) · Brain · doi:10.1093/brain/awt072 · Cited by 13
Cited by
Quantifying prion disease penetrance using large population control cohorts
Minikel, E. V., Vallabh, S. M., Lek, M., Estrada, K., Samocha, K. E., Sathirapongsasuti, J. F., McLean, C. Y., Tung, J. Y., Yu, L. P. C., Gambetti, P., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aad5169 · Cited by 442
Induction of a transmissible tau pathology by traumatic brain injury
Zanier, E. R., Bertani, I., Sammali, E., Pischiutta, F., Chiaravalloti, M. A., Vegliante, G., Masone, A., Corbelli, A., Smith, D. H., Menon, D. K., et al. (2018) · Brain · doi:10.1093/brain/awy193 · Cited by 136
“, 2016) and prion inoculation in mice (Bouybayoune et al., 2015)].”
BackgroundSelf-citationFatal familial insomnia and sporadic fatal insomnia
Cracco, L., Appleby, B. S., & Gambetti, P. L. (2018) · Handbook of clinical neurology · doi:10.1016/b978-0-444-63945-5.00015-5 · Cited by 105
Most sleep does not serve a vital function: Evidence from Drosophila melanogaster
Geissmann, Q., Beckwith, E. J., & Gilestro, G. F. (2019) · Science Advances · doi:10.1126/sciadv.aau9253 · Cited by 75
Fatal Familial Insomnia: Clinical Aspects and Molecular Alterations
Llorens, F., Zarranz, J. J., Fischer, A., Zerr, I., & Ferrer, I. (2017) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-017-0743-0 · Cited by 70
Metadata
- Authors
- Bouybayoune, I., Mantovani, S., Del Gallo, F., Bertani, I., Restelli, E., Comerio, L., Tapella, L., Baracchi, F., Fernández-Borges, N., Mangieri, M., Bisighini, C., Beznoussenko, G. V., Paladini, A., Balducci, C., Micotti, E., Forloni, G., Castilla, J., Fiordaliso, F., Tagliavini, F., Imeri, L., & Chiesa, R.
- Affiliations
- Mario Negri Institute for Pharmacological Research (IT)
- University of Milan (IT)
- Fondazione IRCCS Istituto Neurologico Carlo Besta (IT)
- IFOM (IT)
- Corresponding author
- Chiesa, Roberto
- ORCID
- Venue
- PLOS Pathogens
- Publisher
- Public Library of Science (PLoS)
- Published
- 2015-04-16
- Volume
- 11
- Issue
- 4
- Pages
- e1004796
- ISSN
- 1553-7366 (ISSN-L)
- 1553-7374
- PMC
- PMC4400166
- OpenAlex
- W2064229986
- Cited by
- 81
- References
- 83
- Citations by year
- 2026: 4 · 2025: 4 · 2024: 6 · 2023: 11 · 2022: 3 · 2021: 8 · 2020: 5 · 2019: 7 · 2018: 9 · 2017: 10 · 2016: 11 · 2015: 3
- FWCI
- 4.78
- Type
- journal article
- Language
- en
- Update notices
- correction (2015-07-06)
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS Pathogens (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Fondazione Cariplo (2012-0560, RF-INN-2008-1215065, TDRC00508TU, 2010-0828, RF-2010-2314035)
- Ministero della Salute (RF 2010, TDRC00508TU, RF-2010-2314035, 2010-0828, RF-INN-2008-1215065)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Prion Diseases and Protein Misfolding
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Internal Medicine › Amyloidosis: Diagnosis, Treatment, Outcomes
- Keywords
- fatal familial insomnia, Creutzfeldt-Jakob disease, transgenic mice, prion protein misfolding, prion strains, sleep disruption, endoplasmic reticulum, Golgi apparatus, secretory transport, neurodegeneration
- MeSH terms
- Prion Proteins, Animals, Brain, Disease Models, Animal, Electroencephalography, Magnetic Resonance Imaging, Mice, Inbred C57BL, Mice, Transgenic, Mutation, Phenotype, Prions, Maze Learning, Insomnia, Fatal Familial, Microscopy, Electron, Transmission, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.